These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 32495405)

  • 41. Evaluation of Advanced Therapy Medicinal Products by the National Institute for Health and Care Excellence (NICE): An Updated Review.
    Pinho-Gomes AC; Cairns J
    Pharmacoecon Open; 2022 Mar; 6(2):147-167. PubMed ID: 34415514
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 19th Annual Meeting of the Safety Pharmacology Society: regulatory and safety perspectives for advanced therapy medicinal products (cellular and gene therapy products).
    Cavero I; Seimetz D; Koziel D; Zimmermann WH; Holzgrefe HH
    Expert Opin Drug Saf; 2020 May; 19(5):553-558. PubMed ID: 32163309
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Risk of discontinuation of Advanced Therapy Medicinal Products clinical trials.
    Hanna E; Rémuzat C; Auquier P; Toumi M
    J Mark Access Health Policy; 2016; 4():. PubMed ID: 27570614
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HTA methodology and value frameworks for evaluation and policy making for cell and gene therapies.
    Coyle D; Durand-Zaleski I; Farrington J; Garrison L; Graf von der Schulenburg JM; Greiner W; Longworth L; Meunier A; Moutié AS; Palmer S; Pemberton-Whiteley Z; Ratcliffe M; Shen J; Sproule D; Zhao K; Shah K
    Eur J Health Econ; 2020 Dec; 21(9):1421-1437. PubMed ID: 32794011
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Technology forecast: advanced therapies in late clinical research, EMA approval or clinical application via hospital exemption.
    Eder C; Wild C
    J Mark Access Health Policy; 2019; 7(1):1600939. PubMed ID: 31069029
    [No Abstract]   [Full Text] [Related]  

  • 46. CAT--the new committee for advanced therapies at the European Medicines Agency.
    Celis P
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Jan; 53(1):9-13. PubMed ID: 20084354
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.
    Forbes C; Shirran L; Bagnall AM; Duffy S; ter Riet G
    Health Technol Assess; 2001; 5(28):1-110. PubMed ID: 11701100
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Academic cell therapy facilities are challenged by European regulation on advanced therapy medicinal products].
    Chabannon C; Sabatier F; Rial-Sebbag E; Calmels B; Veran J; Magalon G; Lemarie C; Mahalatchimy A
    Med Sci (Paris); 2014 May; 30(5):576-83. PubMed ID: 24939546
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Challenges and opportunities for access to Advanced Therapy Medicinal Products in Brazil.
    Sachetti CG; Barbosa A; de Carvalho ACC; Araujo DV; da Silva EN
    Cytotherapy; 2024 Aug; 26(8):939-947. PubMed ID: 38639672
    [TBL] [Abstract][Full Text] [Related]  

  • 50. New Medicines in Wales: The All Wales Medicines Strategy Group (AWMSG) Appraisal Process and Outcomes.
    Varnava A; Bracchi R; Samuels K; Hughes DA; Routledge PA
    Pharmacoeconomics; 2018 May; 36(5):613-624. PubMed ID: 29520603
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prospects of Advanced Therapy Medicinal Products-Based Therapies in Regenerative Dentistry: Current Status, Comparison with Global Trends in Medicine, and Future Perspectives.
    Bakopoulou A
    J Endod; 2020 Sep; 46(9S):S175-S188. PubMed ID: 32950189
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Advanced therapy medicinal product manufacturing under the hospital exemption and other exemption pathways in seven European Union countries.
    Coppens DGM; Hoekman J; De Bruin ML; Slaper-Cortenbach ICM; Leufkens HGM; Meij P; Gardarsdottir H
    Cytotherapy; 2020 Oct; 22(10):592-600. PubMed ID: 32563611
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cell based advanced therapeutic medicinal products for bone repair: Keep it simple?
    Leijten J; Chai YC; Papantoniou I; Geris L; Schrooten J; Luyten FP
    Adv Drug Deliv Rev; 2015 Apr; 84():30-44. PubMed ID: 25451134
    [TBL] [Abstract][Full Text] [Related]  

  • 54. NHS general dentistry in Wales: evaluation of patient access and budget expenditure.
    Owen C; Seddon C; Clarke K; Bysouth T
    Br Dent J; 2019 Jun; 226(12):967-978. PubMed ID: 31253919
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ixekizumab for Treating Moderate-to-Severe Plaque Psoriasis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
    Ramaekers BLT; Wolff RF; Pouwels X; Oosterhoff M; Van Giessen A; Worthy G; Noake C; Armstrong N; Kleijnen J; Joore MA
    Pharmacoeconomics; 2018 Aug; 36(8):917-927. PubMed ID: 29480455
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Methodological Characteristics of Clinical Trials Supporting the Marketing Authorisation of Advanced Therapies in the European Union.
    Iglesias-Lopez C; Agustí A; Vallano A; Obach M
    Front Pharmacol; 2021; 12():773712. PubMed ID: 34916948
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gene and cell therapy for children--new medicines, new challenges?
    Buckland KF; Bobby Gaspar H
    Adv Drug Deliv Rev; 2014 Jun; 73(100):162-9. PubMed ID: 24583376
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Powered mobility interventions for very young children with mobility limitations to aid participation and positive development: the EMPoWER evidence synthesis.
    Bray N; Kolehmainen N; McAnuff J; Tanner L; Tuersley L; Beyer F; Grayston A; Wilson D; Edwards RT; Noyes J; Craig D
    Health Technol Assess; 2020 Oct; 24(50):1-194. PubMed ID: 33078704
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Regulation of advanced therapy medicinal products in Europe and the role of academia.
    Pearce KF; Hildebrandt M; Greinix H; Scheding S; Koehl U; Worel N; Apperley J; Edinger M; Hauser A; Mischak-Weissinger E; Dickinson AM; Lowdell MW
    Cytotherapy; 2014 Mar; 16(3):289-97. PubMed ID: 24113428
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.